Doctor’s orders: Atlanta’s prescribed growth in infusion therapy
- Surging pharmaceutical and technological innovations are expected to accelerate outpatient care over the next decade, driving significant growth in infusion therapy.
- Additionally, the confluence of growth in the 65 and older demographic and higher use of Medicare Advantage plans that heavily prioritize lower cost care sites—like infusion therapy instead of surgery—will be a force multiplier for infusion therapy.
- Here we leverage our AI model to find true unmet demand for infusion therapy in the Atlanta market. Explore how our model can identify the highest opportunity sites for nearly 30 medical service lines.
April 19, 2024
